EUVIMEDEUVIMED entdecken
Übersichtsarbeit

An Update on the Recent Advances and Discovery of Novel Tubulin Colchicine Binding Inhibitors

Haoxiang Weng, Jinlong Li, Huajian Zhu, Kei Fung Carver Wong, Zheying Zhu, Jinyi Xu iD

Future Medicinal Chemistry · 2023-01 · 15 (1) · 73-95

DOI: 10.4155/fmc-2022-0212 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Future Medicinal Chemistry, online erschienen am 09.02.2023. Verfasst von Haoxiang Weng und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines & Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, 210009, P…. Hauptthemen laut MEDLINE: Tubulin Modulators, Antineoplastic Agents. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 112 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microtubules, formed by α- and β-tubulin heterodimer, are considered as a major target to prevent the proliferation of tumor cells. Microtubule-targeted agents have become increasingly effective anticancer drugs. However, due to the relatively sophisticated chemical structure of taxane and vinblastine, their application has faced numerous obstacles. Conversely, the structure of colchicine binding site inhibitors (CBSIs) is much easier to be modified. Moreover, CBSIs have strong antiproliferative effect on multidrug-resistant tumor cells and have become the mainstream research orientation of microtubule-targeted agents. This review focuses mainly on the recent advances of CBSIs during 2017-2022, attempts to depict their biological activities to analyze the structure-activity relationships and offers new perspectives for designing next generation of novel CBSIs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tubulin ModulatorsAntineoplastic AgentsColchicineTubulinProtein BindingBinding SitesStructure-Activity RelationshipCell ProliferationCell Line, Tumor

Stichwörter der Autor:innen

SARsantiproliferative effectcolchicine binding sitestructure modificationtubulin polymerization inhibitors

Substanzen

Tubulin ModulatorsColchicineTubulinAntineoplastic Agents

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines & Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, 210009, PR China.
  • School of Pharmacy, The University of Nottingham, University Park Campus, Nottingham, NG7 2RD, UK.

ORCID-Profile: Jinyi Xu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Weng, H., Li, J., Zhu, H., Carver Wong, K. F., Zhu, Z., & Xu, J. (2023). An Update on the Recent Advances and Discovery of Novel Tubulin Colchicine Binding Inhibitors. Future Medicinal Chemistry, 15(1), 73-95. https://doi.org/10.4155/fmc-2022-0212

Vancouver

Weng H, Li J, Zhu H, Carver Wong KF, Zhu Z, Xu J. An Update on the Recent Advances and Discovery of Novel Tubulin Colchicine Binding Inhibitors. Future Medicinal Chemistry. 2023;15(1):73-95. doi:10.4155/fmc-2022-0212

BibTeX
@article{Weng2023,
  author = {Weng, Haoxiang and Li, Jinlong and Zhu, Huajian and Carver Wong, Kei Fung and Zhu, Zheying and Xu, Jinyi},
  title = {An Update on the Recent Advances and Discovery of Novel Tubulin Colchicine Binding Inhibitors},
  journal = {Future Medicinal Chemistry},
  year = {2023},
  volume = {15},
  number = {1},
  pages = {73--95},
  doi = {10.4155/fmc-2022-0212}
}
Kostenlos starten →